Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Remote care for sleep apnea may rival In-Person visits for blood pressure control

NCT ID NCT06064630

Disease control Sponsor: Peking University People's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether managing sleep apnea remotely with a breathing device (APAP) can lower blood pressure as well as traditional in-person care. Researchers enrolled 344 adults with suspected sleep apnea in Beijing. Participants were randomly assigned to either telemedicine-based or outpatient management. The main goal was to see if 24-hour blood pressure improved similarly in both groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Automatic continuous positive airway pressure (APAP) device
What this could lead to
If successful, this could show that remote care for sleep apnea is as effective as in-person visits for lowering blood pressure, making treatment more accessible.
What could go wrong
This is a completed single-center trial, so results may not apply broadly. The study compares management methods, not a new treatment, so the impact is limited to care delivery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

344 people

The number who actually took part.

Started

Nov 2023

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Suspected OSA and recommended to sleep center for HSAT monitoring; 2. Voluntary and signed informed consent; 3. Access to the Internet, email and phone calls; 4. Lived in Beijing for the last three months (subjects randomly assigned to the outpatient treatment group were able to travel to and from the sleep center); 5. Fluent Chinese expression; Exclusion Criteria: 1. Blood pressure cuff should not be used (e.g., circumference of upper arm \> 55cm, history of breast cancer, structural lesions of upper limb); 2. Has been treated with a CPAP or oral appliance; 3. Cardiac insufficiency, NYHA classes III-IV; 4. Clear central sleep apnea (AHI≥15 times/hour, central events \> 50%); 5. Expected life span \< 2 years; 6. Pregnant women; 7. History of kidney failure or kidney transplantation; 8. Attention deficit hyperactivity disorder, use of wakefulness drugs; 9. Less than 5 hours of sleep per night on weekdays combined with other sleep problems (e.g., shift work, night shift, circadian rhythm disturbance); 10. Oxygen is needed when awake or sleeping; 11. Unstable condition: unstable angina pectoris, uncontrolled hypertension, severe COPD, tumor progression, or unstable mental illness;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sleep apnea, obstructive are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sleep apnea, obstructive

Contacts and locations

Locations

  • Peking University People's Hospital

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.